We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Intuitive Surgical develops, manufactures and markets robotic surgical systems, advanced instruments and accessories ... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Robotic-Assisted Bronchoscopy Platform a Game Changer in Lung Cancer Detection and Biopsy Technology

By HospiMedica International staff writers
Posted on 16 Dec 2022
Print article
Image: Ion is a robotic-assisted endoluminal platform for minimally invasive peripheral lung nodule biopsy (Photo courtesy of Intuitive)
Image: Ion is a robotic-assisted endoluminal platform for minimally invasive peripheral lung nodule biopsy (Photo courtesy of Intuitive)

Lung cancer is the leading cause of cancer death among both men and women. According to the World Health Organization, cancer in its myriad forms accounted for 10 million deaths worldwide in 2020; of that multitude, lung cancer accounted for 1.8 million deaths globally - the single largest share by type of cancer. More than half of people with lung cancer die within one year of being diagnosed. Detecting lung cancer early is a way we can fight back. However, early detection can be challenging in part because around 70% of cancerous lung nodules are found in the outer third of the lung, which may be difficult to reach and adequately biopsy via bronchoscopy. Now, the next innovation in lung nodule biopsy uses robotic-assisted surgery that allows clinicians to reach and biopsy difficult-to-reach nodules in the peripheral lung, eliminating the need for multiple biopsies prior to lung cancer diagnosis.

Intuitive Surgical’s (Silicon Valley, CA, USA) Ion is a robotic-assisted endoluminal platform for minimally invasive peripheral lung nodule biopsy. Using Ion’s fully articulating catheter, physicians can identify a target, plan a path to the pulmonary nodule, and navigate far into the periphery of the lung for biopsy. Ion’s ultrathin, ultramaneuverable catheter allows physicians to reach small lesions in all 18 segments of the lung while its unprecedented stability enables the precision needed for biopsy.

Intuitive Surgical has enhanced Ion’s biopsy workflow by integrating Ion and Siemens Healthineers’ Cios Spin mobile imaging system. With this connection, a 3D scan is performed by Cios Spin and automatically sent to the Ion system. From the Ion console touchscreen, the physicians can now refine navigation and verify tool-in-lesion. The integration offers guidance when managing differences in nodule locations seen on preprocedure CT images and intraprocedural imaging.

Ion brings an immersive bronchoscopy experience that begins with planning, moves through procedures, and powers a virtuous cycle of improvement. Ion’s distinct combination of tools and technologies help visualize each patient’s lung anatomy to support biopsy. With Ion, physicians can reach small lesions in the far reaches of the lung. Distal tip articulation allows clinicians to aim the catheter at small targets, even when located outside the airway. Results from early studies have demonstrated relatively low occurrence of pneumothorax requiring intervention. For physicians, Ion provides more reach, more stability, and more precision. This in turn can help them give patients something to hope for - potentially earlier diagnosis.

Related Links:
Intuitive Surgical 

Gold Supplier
Portable X-Ray System
FDR Xair
Digital X-Ray Flat Panel Detector
Plug-In Patient Monitor
Patient Positioning Devices & OR Accessories
SchureMed Tools

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.